Harvard Bioscience, Inc. (HBIO) Improves Q3 EPS to 8c Amid Lower Sales
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.20 +1.99%
EPS Growth %: -800.0%
Financial Fact:
Income before income taxes: -880K
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -800.0%
Financial Fact:
Income before income taxes: -880K
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q3 EPS of $0.08, versus $0.07 reported last year. Revenue for the quarter came in at $26.1 million, versus $26.4 million reported last year.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Chargepoint Holdings Inc. (CHPT) Tops Q2 EPS by 25c, Beats on Revenue
- C3.ai (AI) Tops Q1 EPS by 5c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
